Health

Source link : https://newshealth.biz/health-news/non-doctors-now-handle-40-of-antipsychotic-scripts-in-medicare/ The share of antipsychotic prescriptions by nonphysician clinicians rose from 2013 to 2023 for Medicare beneficiaries, while physician prescribing fell. A shortage of psychiatrists and high Medicare opt-out rates may have shifted antipsychotic management to APRNs and PAs over the decade. The findings may also reflect the expanding role of nonphysician clinicians in nursing homes. […] […] More

Source link : https://newshealth.biz/health-news/alzheimers-blood-tests-together-improve-accuracy-cut-overdiagnosis/ Alzheimer’s can be detected early with p-tau blood biomarkers, but some tests can lead to overdiagnosis. Combining p-tau217 and eMTBR-tau243 may refine diagnostic accuracy and reduce false-positives. Plasma eMTBR-tau243 also could help identify people with high tau burden. A combination of two blood tests improved Alzheimer’s disease triaging and reduced overdiagnosis in people with asymptomatic […] […] More

Source link : https://newshealth.biz/health-news/first-in-class-kras-degrader-promising-in-pancreatic-lung-cancers/ While a number of therapies are approved for use against KRAS G12C mutations, including non-small cell lung cancer, no targeted therapies directed against KRAS G12D have FDA approval. In a phase I trial, setidegrasib showed efficacy in patients with previously treated advanced KRAS G12D-mutated pancreatic ductal adenocarcinoma or non-small cell lung cancer. The treatment was […] […] More

Source link : https://newshealth.biz/health-news/estradiol-patch-matches-lhrh-agonists-for-locally-advanced-prostate-cancer/ Transdermal estradiol patches and LHRH agonists led to similar metastasis-free and overall survival in locally advanced prostate cancer. Estradiol was associated with substantially lower incidence of hot flashes but substantially more gynecomastia. Unlike oral estrogen, transdermal estradiol avoids first-pass hepatic metabolism, lowering the risk of thromboembolic cardiovascular complications. Transdermal estradiol for locally advanced prostate cancer […] […] More

Source link : https://newshealth.biz/health-news/fda-approves-new-drug-combo-for-tough-to-treat-ovarian-cancer/ The FDA approved relacorilant (Lifyorli) in combination with nab-paclitaxel (Abraxane) for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The combination of the selective glucocorticoid receptor antagonist and chemotherapy drug is indicated for patients who have received one to three prior lines of therapy, at least one of which […] […] More

Source link : https://newshealth.biz/health-news/first-glucocorticoid-ra-approved-for-ovarian-cancer/ Relacorilant enhances chemotherapy sensitivity in platinum-resistant disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/first-glucocorticoid-receptor-antagonist-approved-ovarian-2026a100096f?src=rss Author : Publish date : 2026-03-25 20:36:00 Copyright for syndicated content belongs to the linked Source. The post First Glucocorticoid RA Approved for Ovarian Cancer first appeared on News Health. —- Author : News Health Publish date : 2026-03-25 20:36:00 Copyright for […] More

Source link : https://newshealth.biz/health-news/psychedelic-eased-symptoms-of-treatment-resistant-depression/ A single day of treatment with the inhaled psychedelic GH001 led to significant improvements in symptoms among patients with treatment-resistant depression. No severe or serious adverse events were reported with the drug. The median length of psychoactive effect ranged from 9 to 14 minutes with 6-, 12-, and 18-mg doses of GH001. An individualized dosing […] […] More

Source link : https://newshealth.biz/health-news/cause-of-adhd-drug-shortage-tech-addiction-in-patient-detox-paternal-depression/ The 2022-2023 nationwide shortage of stimulant medications for attention deficit-hyperactivity disorder (ADHD) may have been driven by international supply chain disruptions rather than overprescribing, an economic evaluation suggested. (JAMA Health Forum) One psychiatrist detailed what’s actually happening in a brain with ADHD. (The Telegraph) In Australia, the psychedelic drug MDMA is showing promise — without […] […] More

Source link : https://newshealth.biz/health-news/the-vasectomy-conversation-guideline-reflects-changes-in-patients-talking-points/ The American Urological Association guideline emphasizes that vasectomy is a safe, permanent contraceptive option with no evidence of a causal link to prostate cancer. Procedures have spiked since 2022, with more young, childless, and single men seeking the surgery. The guideline encourages thorough preoperative counseling, nonopioid pain management, and discussing future fertility restoration options. Vasectomy […] […] More

Source link : https://newshealth.biz/health-news/rates-of-induced-labor-have-jumped-in-the-past-decade/ Labor induction has risen across demographic groups and gestational age categories during the past decade, an analysis of National Vital Statistics System data found. Among singleton deliveries, induction of labor rates increased from 24.9% in 2016 to 34.5% in 2024, reported Joyce Martin, MPH, and Michelle Osterman, MHS, of the CDC’s division of vital statistics, […] […] More

Source link : https://newshealth.biz/health-news/food-safety-scientist-wins-prize-for-preventing-millions-of-foodborne-illness-cases/ A scientist who pioneered the modern food processing safety standards used around the world was awarded this year’s World Food Prize, the organization announced Wednesday, crediting his work for averting millions of cases of foodborne illness and reducing food waste. Huub Lelieveld, PhD, of the Netherlands earned the award after six decades spent advancing ways […] […] More

Source link : https://newshealth.biz/health-news/ai-may-drive-health-costs-up-doc-economist-says/ In this series, MedPage Today is asking healthcare economists and policy experts the same questions about the high costs of U.S. healthcare. They’ll reveal what they believe is working, what’s not working, and what else can be done to bring costs down. In this interview, Ben Sommers, MD, PhD, a primary care physician and professor […] […] More